A pulse oximeter is a non-invasive medical device designed to monitor a person's oxygen saturation ($SpO_2$) and heart rate. By utilizing light-emitting diodes (LEDs) and a photodetector, the device measures the percentage of hemoglobin in the blood that is saturated with oxygen. This article provides a neutral, evidence-based examination of pulse oximetry technology, clarifying the foundational principles of spectrophotometry and photoplethysmography, the core mechanical and biological mechanisms of oxygen transport measurement, and the objective landscape of clinical accuracy and regulatory standards. The following sections will analyze the structural components of the device, discuss the physics of light absorption in arterial blood, present the regulatory frameworks established by global health authorities, and conclude with a factual question-and-answer session regarding operational constraints and data interpretation.
The primary objective of pulse oximetry is to provide a real-time, non-invasive assessment of peripheral oxygen saturation. Unlike arterial blood gas (ABG) analysis, which requires an invasive blood draw and laboratory processing, pulse oximetry offers immediate data without penetrating the skin.
The device provides two primary metrics:
According to the World Health Organization (WHO), pulse oximetry is a critical tool in clinical settings for monitoring patients under anesthesia, during neonatal care, and for managing respiratory conditions. The technology is based on the premise that oxygenated and deoxygenated hemoglobin absorb light differently at specific wavelengths.
The functionality of a pulse oximeter is governed by the principles of Spectrophotometry and Photoplethysmography (PPG).
The device utilizes two specific wavelengths of light: Red light (approximately 660 nm) and Infrared light (approximately 940 nm).
To distinguish arterial blood from venous blood, skin, and bone, the device relies on the pulsatile nature of arterial flow.
The mathematical foundation of this measurement is the Beers-Lambert Law, which relates the attenuation of light to the properties of the material through which the light is traveling.
Where $A$ is absorbance, $\epsilon$ is the molar absorptivity, $c$ is the concentration of the substance, and $l$ is the path length. In pulse oximetry, this allows the calculation of hemoglobin concentration ratios based on the intensity of transmitted light.
The landscape of pulse oximetry is defined by standardized accuracy requirements and a documented range of physiological limitations.
In the United States, pulse oximeters used for medical purposes are regulated as Class II medical devices by the Food and Drug Administration (FDA).
Research indexed by the National Institutes of Health (NIH) highlights several factors that can objectively affect the accuracy of a reading:
Pulse oximetry is currently transitioning toward Multi-Wavelength Sensors and Reflectance Oximetry. The future outlook involves the development of sensors capable of measuring additional parameters, such as carboxyhemoglobin (COHb) and methemoglobin (MetHb), which currently require specialized hospital equipment.
Furthermore, there is an industry move toward "Continuous Wearable Monitoring." As wireless technology improves, integrated pulse oximeters in smartwatches and rings are being evaluated for their role in long-term data collection, provided they can overcome the mechanical challenges of motion artifacts and variable contact pressure.
Q: Why does the device not provide an accurate reading if the patient has carbon monoxide poisoning?
A: Pulse oximeters cannot distinguish between oxygenated hemoglobin and carboxyhemoglobin because both absorb light similarly at the 660 nm wavelength. Consequently, a patient with carbon monoxide poisoning may display a "normal" $SpO_2$ reading of 98% despite severe oxygen deprivation.
Q: Is a reading of 95% the same for everyone?
A: While 95-100% is generally considered the standard range for healthy individuals at sea level, "normal" is relative to an individual's baseline. Chronic conditions like COPD (Chronic Obstructive Pulmonary Disease) may result in lower baseline saturation levels that are considered normal for that specific clinical context.
Q: Does altitude affect the $SpO_2$ reading?
A: Yes. At higher altitudes, the atmospheric pressure is lower, leading to a decrease in the partial pressure of oxygen. This results in a lower percentage of hemoglobin being saturated, which the pulse oximeter will accurately reflect as a lower $SpO_2$ value.